NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Nov 09 2022

· Issued by NATCO Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-09-2022-13

Natco Pharma Limited has informed the Exchange about press release dated 09-Nov-2022 titled Launch of First Generic Version of Pomalyst�� (Pomalidomide) Capsules in the Australian Market

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

In the deck

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases